2,292
Views
0
CrossRef citations to date
0
Altmetric
Cancer Biology

Identification of target genes and prognostic evaluation for colorectal cancer using integrated bioinformatics analysis

ORCID Icon, ORCID Icon, , , &
Pages 160-173 | Received 22 Sep 2021, Accepted 05 Jan 2022, Published online: 20 Jan 2022

References

  • Barras D, Missiaglia E, Wirapati P, et al. 2017. BRAF v600e Mutant colorectal cancer subtypes based on gene expression. Clin Cancer Res. 23(1):104–115.
  • Benard F, Barkun AN, Martel M, et al. 2018. Systematic review of colorectal cancer screening guidelines for average-risk adults: summarizing the current global recommendations. World J Gastroenterol. 24(1):124–138.
  • Boussios S, Ozturk MA, Moschetta M, et al. 2019. The developing story of predictive biomarkers in colorectal cancer. J Pers Med. 9(1):12.
  • Branchi V, Garcia SA, Radhakrishnan P, et al. 2019. Prognostic value of DLGAP5 in colorectal cancer. Int J Colorectal Dis. 34(8):1455–1465.
  • Buzzetti M, Morlando S, Solomos D, et al. 2021. Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells. Sci Rep. 11(1):5374.
  • Cai J, Wang H, Jiao X, et al. 2019. The RNA-binding protein HuR confers oxaliplatin resistance of colorectal cancer By upregulating CDC6. Mol Cancer Ther. 18(7):1243–1254.
  • Canzoneri R, Lacunza E, Abba MC. 2019. Genomics and bioinformatics as pillars of precision medicine in oncology. Medicina (B Aires). 79(Spec 6/1):587–592.
  • Chang IW, Lin VC, He HL, et al. 2015. CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. Am J Transl Res. 7(4):710–722.
  • Chin CH, Chen SH, Wu HH, et al. 2014. Cytohubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 8(Suppl 4):S11.
  • Condorelli DF, Spampinato G, Valenti G‚ et al. 2018. Positive Caricature Transcriptomic Effects Associated with Broad Genomic Aberrations in Colorectal Cancer. Scientific Reports. 8(1):14826.
  • Du J, Yuan Z, Ma Z, et al. 2014. KEGG-PATH: Kyoto encyclopedia of genes and genomes-based pathway analysis using a path analysis model. Mol BioSyst. 10(9):2441–2447.
  • El Sharkawi FZ, El Shemy HA, Khaled HM. 2014. Possible anticancer activity of rosuvastatine, doxazosin, repaglinide and oxcarbazepin. Asian Pacific Journal of Cancer Prevention: APJCP. 15(1):199–203.
  • English EJ, Mahn SA, Marchese A. 2018. Endocytosis is required for CXC chemokine receptor type 4 (CXCR4)-mediated Akt activation and antiapoptotic signaling. J Biol Chem. 293(29):11470–11480.
  • Erdogan B, Webb DJ. 2017. Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis. Biochem Soc Trans. 45(1):229–236.
  • Fang Y, Yu H, Liang X, et al. 2014. Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer. Cancer Biol Ther. 15(9):1268–1279.
  • Gan Y, Li Y, Li T, et al. 2018. CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer. Cancer Manag Res. 10:5113–5124.
  • Haneke K, Schott J, Lindner D, et al. 2020. CDK1 couples proliferation with protein synthesis. J Cell Biol. 219(3):e201906147.
  • Hinderer 3rd EW, Flight RM, Dubey R, et al. 2019. Advances in gene ontology utilization improve statistical power of annotation enrichment. PloS one. 14(8):e0220728.
  • Howard D, James D, Murphy K, et al. 2021. Dinaciclib, a bimodal agent effective against endometrial cancer. Cancers (Basel. 13(5):1135.
  • Jacobsen A, Bosch LJW, Martens-de Kemp SR, et al. 2018. Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer. Sci Rep. 8(1):7522.
  • Ji J, Shen T, Li Y, et al. 2021. CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway. Oncol Rep. 45(3):921–932.
  • Jiang P, Liu XS. 2015. Big data mining yields novel insights on cancer. Nat Genet. 47(2):103–104.
  • Jiao X, Sherman BT, Huang da W, et al. 2012. DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics. 28(13):1805–1806.
  • Kalous J, Jansova D, Susor A. 2020. Role of cyclin-dependent kinase 1 in translational regulation in the M-phase. Cells. 9(7):1568.
  • Keum N, Giovannucci E. 2019. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nature Reviews Gastroenterology & Hepatology. 16(12):713–732.
  • Miller I, Min M, Yang C, et al. 2018. Ki67 is a graded rather than a binary marker of proliferation versus quiescence. Cell Rep. 24(5):1105–1112. e5.
  • Mlecnik B, Galon J, Bindea G. 2018. Comprehensive functional analysis of large lists of genes and proteins. J Proteomics. 171:2–10.
  • Otasek D, Morris JH, Boucas J, et al. 2019. Cytoscape automation: empowering workflow-based network analysis. Genome Biol. 20(1):185.
  • Rigoglio NN, Rabelo ACS, Borghesi J, et al. 2020. The tumor microenvironment: focus on extracellular matrix. Adv Exp Med Biol. 1245:1–38.
  • Shen A, Liu L, Chen H, et al. 2019. Cell division cycle associated 5 promotes colorectal cancer progression by activating the ERK signaling pathway. Oncogenesis. 8(3):19.
  • Siegel RL, Miller KD, Jemal A. 2019. Cancer statistics, 2019. CA Cancer J Clin. 69(1):7–34.
  • Sinha D, Duijf PHG, Khanna KK. 2019. Mitotic slippage: an old tale with a new twist. Cell Cycle. 18(1):7–15.
  • Subramanian A, Narayan R, Corsello SM, et al. 2017. A next generation Connectivity Map: L1000 platform and the First 1,000,000 profiles. Cell. 171(6):1437–1452. e17.
  • Sung H, Ferlay J, Siegel RL. 2021. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 71(3):209–249.
  • Szklarczyk D, Gable AL, Nastou KC, et al. 2021. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 49(D1):D605–d612.
  • Takahashi Y, Sheridan P, Niida A, et al. 2015. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC. Annals of Oncology: Official Journal of the European Society for Medical Oncology. 26(5):935–942.
  • Tang Z, Li C, Kang B, et al. 2017. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45(W1):W98–W102.
  • Varol C, Sagi I. 2018. Phagocyte-extracellular matrix crosstalk empowers tumor development and dissemination. FEBS J. 285(4):734–751.
  • Vlachavas EI, Pilalis E, Papadodima O‚ et al. 2019. Radiogenomic Analysis of F-18-Fluorodeoxyglucose Positron Emission Tomography and Gene Expression Data Elucidates the Epidemiological Complexity of Colorectal Cancer Landscape. Computational and Structural Biotechnology Journal. 17:177–185.
  • Wang J, Xia C, Pu M, et al. 2018. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma. Oncol Rep. 40(4):1875–1884.
  • Xiao ZX, Chen RQ, Hu DX, et al. 2017. Identification of repaglinide as a therapeutic drug for glioblastoma multiforme. Biochem Biophys Res Commun. 488(1):33–39.
  • Xu W, McArthur G. 2016. Cell cycle regulation and melanoma. Curr Oncol Rep. 18(6):34.
  • Yao S, Liu T. 2018. Analysis of differential gene expression caused by cervical intraepithelial neoplasia based on GEO database. Oncol Lett. 15(6):8319–8324.
  • Zeng Q, Lei F, Chang Y, et al. 2019. An oncogenic gene, SNRPA1, regulates PIK3R1, VEGFC, MKI67, CDK1 and other genes in colorectal cancer. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 117:109076.
  • Zhang P, Kawakami H, Liu W, et al. 2018a. Targeting CDK1 and MEK/ERK overcomes apoptotic resistance in BRAF-Mutant Human colorectal cancer. Molecular Cancer Research: Mcr. 16(3):378–389.
  • Zhang Y, Tian S, Li X‚ et al. 2018b. UBE2C promotes rectal carcinoma via miR-381. Cancer Biology & Therapy. 19(3):230–238.
  • Zhong R, Chen X, Chen X, et al. 2015. MAD1L1 arg558his and MAD2L1 Leu84Met interaction with smoking increase the risk of colorectal cancer. Sci Rep. 5:12202.